Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics Inc (NQ: IOVA )

10.92 -2.53 (-18.81%)
Streaming Delayed Price Updated: 2:33 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 15,337,330
Open 13.04
Bid (Size) 10.91 (5)
Ask (Size) 10.92 (2)
Prev. Close 13.45
Today's Range 10.70 - 13.20
52wk Range 3.210 - 18.33
Shares Outstanding 279,832,722
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Iovance Stock Is Down 18% Today
Investors are misunderstanding when the biopharma company's flagship drug will begin generating meaningful reportable revenue. 
Via The Motley Fool
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga

Performance

YTD
+34.81%
+34.81%
1 Month
-17.40%
-17.40%
3 Month
+25.81%
+25.81%
6 Month
+176.46%
+176.46%
1 Year
+26.39%
+26.39%

More News

Read More
Iovance Biotherapeutics's Options: A Look at What the Big Money is Thinking
Via Benzinga
How Is The Market Feeling About Iovance Biotherapeutics?
Via Benzinga
Is Iovance Biotherapeutics Stock a Buy Now?
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate Updates
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
Via The Motley Fool
Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics to Present at Upcoming Conferences
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
Via The Motley Fool
The Top 3 Biotech Stocks to Buy in April 2024
Via InvestorPlace
3 Millionaire-Maker Biotech Stocks
Via The Motley Fool
Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual Meeting
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Via The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
Via MarketBeat
Topics Cannabis
Exposures Cannabis
Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics
Via The Motley Fool
2 Soaring Growth Stocks That Could Climb Another 47% to 73%, According to Wall Street
Via The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
Via InvestorPlace
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
Via The Motley Fool
Piper Sandler Maintains Overweight Rating for Iovance Biotherapeutics: Here's What You Need To Know
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.